.

Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Obtain formulation and manufacturing information

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Federal Trade Commission
McKesson
Medtronic
Accenture
Citi
Boehringer Ingelheim
Fish and Richardson
QuintilesIMS
Healthtrust
US Department of Justice

Generated: December 16, 2017

DrugPatentWatch Database Preview

Sermorelin acetate - Generic Drug Details

« Back to Dashboard

What are the generic drug sources for sermorelin acetate and what is the scope of sermorelin acetate freedom to operate?

Sermorelin acetate
is the generic ingredient in one branded drug marketed by Emd Serono and Emd Serono Inc, and is included in two NDAs. Additional information is available in the individual branded drug profile pages.

There is one drug master file entry for sermorelin acetate.

Summary for sermorelin acetate

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Emd Serono IncGEREFsermorelin acetateINJECTABLE;INJECTION020443-001Sep 26, 1997DISCNYesNo► Subscribe► Subscribe► Subscribe
Emd Serono IncGEREFsermorelin acetateINJECTABLE;INJECTION020443-002Sep 26, 1997DISCNYesNo► Subscribe► Subscribe► Subscribe
Emd SeronoGEREFsermorelin acetateINJECTABLE;INJECTION019863-001Dec 28, 1990DISCNYesNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Orange Book Patents for Generic Ingredient: sermorelin acetate

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Emd SeronoGEREFsermorelin acetateINJECTABLE;INJECTION019863-001Dec 28, 1990► Subscribe► Subscribe
Emd Serono IncGEREFsermorelin acetateINJECTABLE;INJECTION020443-002Sep 26, 1997► Subscribe► Subscribe
Emd Serono IncGEREFsermorelin acetateINJECTABLE;INJECTION020443-001Sep 26, 1997► Subscribe► Subscribe
Emd Serono IncGEREFsermorelin acetateINJECTABLE;INJECTION020443-002Sep 26, 1997► Subscribe► Subscribe
Emd Serono IncGEREFsermorelin acetateINJECTABLE;INJECTION020443-001Sep 26, 1997► Subscribe► Subscribe
Emd SeronoGEREFsermorelin acetateINJECTABLE;INJECTION019863-001Dec 28, 1990► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Express Scripts
Accenture
Covington
Farmers Insurance
Chinese Patent Office
Johnson and Johnson
Harvard Business School
Novartis
Federal Trade Commission
Dow

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

botpot